Oncology and Hematology
Episodes 1-16 of 128
Daniel P. Petrylak, MD
Elizabeth R. Plimack, MD, MS, FASCO
Evan Y. Yu, MD
Elizabeth R. Plimack, MD, MS, FASCO
Lillibeth Velasco, MSN, RN
- MinuteCE®
Exploring New and Emerging Treatments in Muscle Invasive Bladder Cancer
0.50 program creditsElizabeth R. Plimack, MD, MS, FASCO
Elizabeth R. Plimack, MD, MS, FASCO
Elizabeth R. Plimack, MD, MS, FASCO
Lillibeth Velasco, MSN, RN
Eric Van Cutsem, MD, PhD
David SP Tan, MBBS, PhD, PRCP
James Chih-Hsin Yang, MD, PhD
Kathleen Moore, MD, MS, FASCO
Efrat Dotan, MD
Shubham Pant, MD, MBBS
Efrat Dotan, MD
Shubham Pant, MD, MBBS
Efrat Dotan, MD
Shubham Pant, MD, MBBS
Peter Schmid, FRCP, MD, PhD
- MinuteCE®
Adjuvant Treatments for HR+/HER2- EBC: The Role of CDK4/6 and PARP Inhibitors
1.50 program creditsErica L. Mayer, MD, MPH
William J. Gradishar, MD
Erica L. Mayer, MD, MPH
Peter Schmid, FRCP, MD, PhD
Aparna R. Parikh, MD
Sara Lonardi, MD
Aparna R. Parikh, MD
Alan Venook, MD
- Prev
- Next